Edition:
United Kingdom

Collplant Holdings Ltd (CLGN.OQ)

CLGN.OQ on NASDAQ Stock Exchange Capital Market

5.75USD
21 Feb 2019
Change (% chg)

$0.20 (+3.60%)
Prev Close
$5.55
Open
$5.60
Day's High
$5.75
Day's Low
$5.60
Volume
7,850
Avg. Vol
5,500
52-wk High
$8.73
52-wk Low
$3.13

Latest Key Developments (Source: Significant Developments)

Collplant Holdings Files For Mixed Shelf Of Upto $50 Mln
Friday, 1 Feb 2019 

Feb 1 (Reuters) - Collplant Holdings Ltd ::COLLPLANT HOLDINGS LTD FILES FOR MIXED SHELF OF UPTO $50 MILLION - SEC FILING.  Full Article

Collplant Says David Tsur Notified Co Of Resignation As Chairman And As Member Of Board
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - Collplant Holdings Ltd ::COLLPLANT HOLDINGS SAYS ON JANUARY 1, DAVID TSUR NOTIFIED COMPANY OF RESIGNATION AS CHAIRMAN AND AS MEMBER OF BOARD - SEC FILING.COLLPLANT HOLDINGS SAYS DAVID TSUR'S RESIGNATION EFFECTIVE MARCH 31, 2019, OR EARLIER IF NEW CHAIRPERSON IS APPOINTED.  Full Article

CollPlant And United Therapeutics Announce Global Licensing And Commercialization Agreement
Monday, 22 Oct 2018 

Oct 22 (Reuters) - United Therapeutics Corp ::COLLPLANT AND UNITED THERAPEUTICS ANNOUNCE GLOBAL LICENSING AND COMMERCIALIZATION AGREEMENT FOR 3D BIOPRINTING OF SOLID-ORGAN SCAFFOLDS FOR HUMAN TRANSPLANTS.COLLPLANT WILL RECEIVE AN UPFRONT PAYMENT OF $5 MILLION.COLLPLANT WILL RECEIVE MILESTONE PAYMENTS OF UP TO $15 MILLION.COLLPLANT ENTITLED TO GET ROYALTIES ON SALES OF COMMERCIALIZED PRODUCTS COVERED BY PATENTS LICENSED FROM IT.COLLPLANT WILL MANUFACTURE AND SUPPLY BIOINK FOR A FEW YEARS TO MEET DEVELOPMENT PROCESS DEMAND.COLLPLANT TO GIVE TECHNICAL SUPPORT TO CO AS IT ESTABLISHES U.S. FACILITY FOR MANUFACTURE OF COLLPLANT'S RHCOLLAGEN, BIOINK.  Full Article

Dual-Listed Collplant To Voluntarily Delist From Tel Aviv Stock Exchange
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Collplant Holdings Ltd ::DUAL-LISTED COLLPLANT TO VOLUNTARILY DELIST FROM TEL AVIV STOCK EXCHANGE.  Full Article

CollPlant Received Grant Approval From Israel To Finance Development Of Rhcollagen-Based Formulations
Tuesday, 26 Jun 2018 

June 26 (Reuters) - Collplant Holdings Ltd ::COLLPLANT - RECEIVED GRANT APPROVAL FROM ISRAEL INNOVATION AUTHORITY TO FINANCE CONTINUED DEVELOPMENT OF RHCOLLAGEN-BASED FORMULATIONS.COLLPLANT HOLDINGS - APPROVED PROJECT BUDGET IS APPROXIMATELY $1.2 MILLION, OF WHICH ISRAEL INNOVATION AUTHORITY WILL FINANCE 30 PERCENT.  Full Article

Collplant Petitions Court To Voluntarily Delist Ordinary Shares From The Tel Aviv Stock Exchange
Monday, 16 Apr 2018 

April 16 (Reuters) - Collplant Holdings Ltd ::COLLPLANT PETITIONS COURT TO VOLUNTARILY DELIST ORDINARY SHARES FROM THE TEL AVIV STOCK EXCHANGE.COLLPLANT HOLDINGS LTD - DELISTING FROM THE TASE IS THE NEXT STEP IN CO'S DEVELOPMENT AS "THE COMPANY BECOMES MORE US FACING".  Full Article

CollPlant receives innovation authority approval for R&D Program
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Collplant Holdings Ltd :Says received Ministry Of Economy Innovation Authority's approval for Collplant's research and development program for 2017​.  Full Article

No consensus analysis data available.